Brief: Lipigon Q2 Operating Loss NOK 8.5 Mln
26/08/2025 07:08
Aug 26 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST: Q2 NET SALES NOK 0 Q2 OPERATING LOSS NOK 8.5 MILLION Source text: ID:nBQN2pb4Vv Further company coverage: LPGO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds